Page results
-
Contrast Extravasation (contrast leakage) patient information leaflet
-
We are pleased to have performed very well again in this year's General Medical Council National Training Survey.
-
A UCLH rheumatology team is leading an exciting project to help understand the reasons for young people missing their hospital appointments and find ways to improve this.
-
Information about making a donation to the Haematology Cancer Care charity fund at UCLH
-
This page explains what a low-phosphate diet is. It also provides information about foods you can eat and foods to avoid when taking a medicine called futibatinib.
-
A breathing aid that can help keep Covid-19 patients out of intensive care, adapted by mechanical engineers at UCL and clinicians at UCLH working with Mercedes-AMG High Performance Powertrains (Mercedes-AMG HPP), has been approved for use in the NHS.
-
Taking blood pressure medication in the evening is no better than taking it in the morning, according to new research.
-
The iconic run has returned to its regular time of the year, following two years’ disruption following the pandemic and will take place on Sunday 2 October 2022. We are lucky enough to have five people running for UCLH Charity. The money they raise will help us support patients, staff and research at UCLH.
-
The Integrated Children and Adolescent Service is a long-established outpatient service of the Royal London Hospital for Integrated Medicine at UCLH.
-
Information on contrast agents for X-ray, fluoroscopy, CT and angiography examinations at NHNN
File results
-
FOI/2022/0602 - Number of patients admitted for lung diseases over a five year period
-
FOI/2022/0601 - Admission for babies declined for level 3 neonatal intensive care unit
-
FOI/2022/0594 - Hotels and taxis for out-of-area patients and their next of kin
-
FOI/2022/0592 - A&E/ document management/ digital dictation/ scheduling IT systems
-
FOI/2022/0591 - Maternity guidelines relating to obesity
-
FOI/2022/0590 - Private patient unit revenue
-
FOI/2022/0589 - Multiple sclerosis treatment
-
FOI/2022/0513 - Myelofibrosis treatment
-
FOI/2022/0541 - Serious Incidents Level 2 deaths/ serious harm
-
FOI/2022/0540 - Electronic patient record